BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37508201)

  • 41. Route of nutrition and risk of blood stream infections in critically ill patients; a comparative study.
    Gavri C; Kokkoris S; Vasileiadis I; Oeconomopoulou AC; Kotanidou A; Nanas S; Routsi C
    Clin Nutr ESPEN; 2016 Apr; 12():e14-e19. PubMed ID: 28531664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk Factors and Outcomes of Multidrug-Resistant Bacteria Infection in Infected Pancreatic Necrosis Patients.
    Lu J; Ding Y; Qu Y; Mei W; Guo Y; Fang Z; Qu C; Gao C; Cao F; Li F; Feng Y
    Infect Drug Resist; 2022; 15():7095-7106. PubMed ID: 36483142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of Effective Antimicrobial Regimens and Mortality-Related Risk Factors for Bloodstream Infections Caused by Carbapenem-Resistant
    Gu S; Xiong J; Peng S; Hu L; Zhu H; Xiao Y; Luo H; Hang Y; Chen Y; Fang X; Cao X; Fang Y; Li F; Zhu J; Zhong Q
    Infect Drug Resist; 2023; 16():2589-2600. PubMed ID: 37152405
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Threat of Carbapenem-Resistant Gram-Negative Bacteria in Patients with Hematological Malignancies: Unignorable Respiratory Non-Fermentative Bacteria-Derived Bloodstream Infections.
    Lu L; Xu C; Tang Y; Wang L; Cheng Q; Chen X; Zhang J; Li Y; Xiao H; Li X
    Infect Drug Resist; 2022; 15():2901-2914. PubMed ID: 35693849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
    Chen J; Ma H; Huang X; Cui Y; Peng W; Zhu F; Ma S; Rao M; Zhang P; Yang H; Su L; Niu R; Pan P
    Antimicrob Resist Infect Control; 2022 Dec; 11(1):161. PubMed ID: 36536423
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared.
    Cogliati Dezza F; Arcari G; Alessi F; Valeri S; Curtolo A; Sacco F; Ceccarelli G; Raponi G; Alessandri F; Mastroianni CM; Venditti M; Oliva A
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ecological effects of selective oral decontamination on multidrug-resistance bacteria acquired in the intensive care unit: a case-control study over 5 years.
    Wang B; Briegel J; Krueger WA; Draenert R; Jung J; Weber A; Bogner J; Schubert S; Liebchen U; Frank S; Zoller M; Irlbeck M; Ney L; Weig T; Hinske L; Niedermayer S; Kilger E; Möhnle P; Grabein B
    Intensive Care Med; 2022 Sep; 48(9):1165-1175. PubMed ID: 35953676
    [TBL] [Abstract][Full Text] [Related]  

  • 48.
    Andrianopoulos I; Maniatopoulou T; Lagos N; Kazakos N; Papathanasiou A; Papathanakos G; Koulenti D; Kittas C; Koulouras V
    Microorganisms; 2023 Jul; 11(7):. PubMed ID: 37512983
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidemiology of
    Tian L; Tan R; Chen Y; Sun J; Liu J; Qu H; Wang X
    Antimicrob Resist Infect Control; 2016; 5():48. PubMed ID: 27891222
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections: A retrospective analysis.
    Xia G; Jiang R
    Medicine (Baltimore); 2020 Mar; 99(10):e19466. PubMed ID: 32150105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk Factors for Mortality in Adult COVID-19 Patients Who Develop Bloodstream Infections Mostly Caused by Antimicrobial-Resistant Organisms: Analysis at a Large Teaching Hospital in Italy.
    Posteraro B; De Angelis G; Menchinelli G; D'Inzeo T; Fiori B; De Maio F; Cortazzo V; Sanguinetti M; Spanu T
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33920701
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of COVID-19 pandemic on healthcare-associated infections, antibiotic resistance and consumption rates in intensive care units.
    Önal U; Tüzemen Ü; Kazak E; Gençol N; Souleiman E; İmer H; Heper Y; Yılmaz E; Özakın C; Ener B; Akalin H
    Infez Med; 2023; 31(2):195-203. PubMed ID: 37283640
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Surveillance programme for multidrug-resistant bacteria in healthcare-associated infections: an urban perspective in South Brazil.
    Toledo PV; Arend LN; Pilonetto M; Costa Oliveira JC; Luhm KR;
    J Hosp Infect; 2012 Apr; 80(4):351-3. PubMed ID: 22382275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology and outcomes of culture-positive bloodstream pathogens prior to and during the SARS-CoV-2 pandemic: a multicenter evaluation.
    Bauer KA; Puzniak LA; Yu KC; Finelli L; Moise P; Ai C; Watts JA; Gupta V
    BMC Infect Dis; 2022 Nov; 22(1):841. PubMed ID: 36368931
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hospital-acquired bloodstream infections in patients deceased with COVID-19 in Italy (2020-2021).
    Monaco M; Floridia M; Giuliano M; Palmieri L; Lo Noce C; Pantosti A; Palamara AT; Brusaferro S; Onder G;
    Front Med (Lausanne); 2022; 9():1041668. PubMed ID: 36465906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors and predictors of carbapenem-resistant
    Papadimitriou-Olivgeris M; Fligou F; Spiliopoulou A; Koutsileou K; Kolonitsiou F; Spyropoulou A; Zotou A; Marangos M; Anastassiou ED; Christofidou M; Spiliopoulou I
    J Med Microbiol; 2017 Aug; 66(8):1092-1101. PubMed ID: 28758623
    [No Abstract]   [Full Text] [Related]  

  • 57. Acquired bloodstream infection in the intensive care unit: incidence and attributable mortality.
    Prowle JR; Echeverri JE; Ligabo EV; Sherry N; Taori GC; Crozier TM; Hart GK; Korman TM; Mayall BC; Johnson PD; Bellomo R
    Crit Care; 2011; 15(2):R100. PubMed ID: 21418635
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multidrug-Resistant
    Chen Q; Zheng Z; Shi Q; Wu H; Li Y; Zheng C
    Can J Infect Dis Med Microbiol; 2022; 2022():8368578. PubMed ID: 35783362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence, etiology, risk factors, and outcomes of pre-engraftment bloodstream infections after first and second allogeneic hematopoietic cell transplantation.
    Akhmedov M; Klyasova G; Kuzmina L; Fedorova A; Vasilyeva V; Drokov M; Parovichnikova E
    Transpl Infect Dis; 2022 Jun; 24(3):e13842. PubMed ID: 35501664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prognostic Factors of Central Venous Catheter-related Bloodstream Infections].
    Xie ZY; Meng GL; Xiong Y; Li YF; Yang H; Yang ZL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):789-794. PubMed ID: 33423727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.